Dirk Jochmans researcher
Jochmans, Dirk
VIAF ID: 316507038 (Personal)
Permalink: http://viaf.org/viaf/316507038
Preferred Forms
-
100 0 _ ‡a Dirk Jochmans ‡c researcher
-
100 1 _ ‡a Jochmans, Dirk
4xx's: Alternate Name Forms (1)
5xx's: Related Names (1)
Works
Title | Sources |
---|---|
Anti-SARS-CoV-2 activity of cyanopeptolins produced by Nostoc edaphicum CCNP1411 |
![]() |
Antiviral Activity of Favipiravir (T-705) against a Broad Range of Paramyxoviruses In Vitro and against Human Metapneumovirus in Hamsters |
![]() |
Bicyclic and Tricyclic "Expanded" Nucleobase Analogues of Sofosbuvir: New Scaffolds for Hepatitis C Therapies |
![]() |
Design, synthesis and evaluation of a series of acyclic fleximer nucleoside analogues with anti-coronavirus activity |
![]() |
Development and optimization of a high-throughput screening assay for in vitro anti-SARS-CoV-2 activity: Evaluation of 5676 Phase 1 Passed Structures |
![]() |
Differential antiviral activities of respiratory syncytial virus (RSV) inhibitors in human airway epithelium. |
![]() |
Difluoromethylbenzoxazole pyrimidine thioether derivatives: a novel class of potent non-nucleoside HIV-1 reverse transcriptase inhibitors |
![]() |
The enterovirus protease inhibitor rupintrivir exerts cross-genotypic anti-norovirus activity and clears cells from the norovirus replicon |
![]() |
Identification and evaluation of potential SARS-CoV-2 antiviral agents targeting mRNA cap guanine N7-Methyltransferase |
![]() |
In vitro activity of itraconazole against SARS-CoV-2 |
![]() |
Inherited IFNAR1 deficiency in otherwise healthy patients with adverse reaction to measles and yellow fever live vaccines |
![]() |
Inhibition of human immunodeficiency virus type 1 replication in human cells by Debio-025, a novel cyclophilin binding agent |
![]() |
Inhibition of the Replication of Different Strains of Chikungunya Virus by 3-Aryl-[1,2,3]triazolo[4,5-d]pyrimidin-7(6H)-ones. |
![]() |
Intervention strategies for emerging viruses: use of antivirals |
![]() |
Mannitol treatment is not effective in therapy of rabies virus infection in mice |
![]() |
MAPPIT as a high-throughput screening assay for modulators of protein-protein interactions in HIV and HCV. |
![]() |
Mutations in the chikungunya virus non-structural proteins cause resistance to favipiravir (T-705), a broad-spectrum antiviral |
![]() |
Mutations M184V and Y115F in HIV-1 reverse transcriptase discriminate against "nucleotide-competing reverse transcriptase inhibitors". |
![]() |
New HSV-1 Anti-Viral 1'-Homocarbocyclic Nucleoside Analogs with an Optically Active Substituted Bicyclo[2.2.1]Heptane Fragment as a Glycoside Moiety |
![]() |
Norovirus: targets and tools in antiviral drug discovery |
![]() |
A novel druggable interprotomer pocket in the capsid of rhino- and enteroviruses |
![]() |
A novel high-throughput cellular screening assay for the discovery of HIV-1 integrase inhibitors. |
![]() |
A novel kindred with inherited STAT2 deficiency and severe viral illness |
![]() |
A novel method for high-throughput screening to quantify antiviral activity against viruses that induce limited CPE |
![]() |
The path towards effective antivirals against rabies. |
![]() |
Patients with discordant responses to antiretroviral therapy have impaired killing of HIV-infected T cells. |
![]() |
Progress in human picornavirus research: New findings from the AIROPico consortium |
![]() |
Prophylactic treatment with the nucleoside analogue 2'-C-methylcytidine completely prevents transmission of norovirus |
![]() |
Pyrimethamine inhibits rabies virus replication in vitro |
![]() |
Rapid and convenient assays to assess potential inhibitory activity on in vitro hepatitis A replication |
![]() |
Resistance mutations in human immunodeficiency virus type 1 integrase selected with elvitegravir confer reduced susceptibility to a wide range of integrase inhibitors |
![]() |
SARS-CoV-2 Mpro inhibitors and activity-based probes for patient-sample imaging |
![]() |
Screening of an FDA-approved compound library identifies four small-molecule inhibitors of Middle East respiratory syndrome coronavirus replication in cell culture |
![]() |
Selective killing of human immunodeficiency virus infected cells by non-nucleoside reverse transcriptase inhibitor-induced activation of HIV protease. |
![]() |
STAT2 signaling restricts viral dissemination but drives severe pneumonia in SARS-CoV-2 infected hamsters |
![]() |
Ultralarge Virtual Screening Identifies SARS-CoV-2 Main Protease Inhibitors with Broad-Spectrum Activity against Coronaviruses |
![]() |
The viral capping enzyme nsP1: a novel target for the inhibition of chikungunya virus infection. |
![]() |
The viral polymerase inhibitor 2'-C-methylcytidine inhibits Norwalk virus replication and protects against norovirus-induced diarrhea and mortality in a mouse model |
![]() |